Introdução
O que você precisa saber de cara
O algoritmo de Shapiro—Senapathy (S&S) é um método computacional para identificar sítios de *splicing* em genes eucarióticos. O algoritmo emprega uma fórmula de pontuação de Matriz de Ponderação Posicional (PWM) para prever sítios de *splicing* doador e aceptor em um dado gene. Essa metodologia tem sido utilizada para descobrir sítios de *splicing* e mutações em sítios de *splicing* causadoras de doenças no genoma humano, e tornou-se uma ferramenta padrão em genômica clínica.
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 25 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 71 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
1 gene identificado com associação a esta condição.
Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity
NucleusNucleus, nucleolusCell membrane
Neurofibromatosis 1
A disease characterized by patches of skin pigmentation (cafe-au-lait spots), Lisch nodules of the iris, tumors in the peripheral nervous system and fibromatous skin tumors. Individuals with the disorder have increased susceptibility to the development of benign and malignant tumors.
Medicamentos aprovados (FDA)
2 medicamentos encontrados nos registros da FDA americana.
Variantes genéticas (ClinVar)
7,190 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 4 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
2 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Neurofibromatose tipo 1 por mutação ou deleção intragênica em NF1
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Pesquisa e ensaios clínicos
Nenhum ensaio clínico registrado para esta condição.
Publicações mais relevantes
Familial medullary thyroid carcinoma secondary to an SLC30A9 intragenic deletion and translation reinitiation.
While most individuals with familial medullary thyroid carcinoma (fMTC) carry RET mutations, in some instances the causative mutations remain unknown. We studied two related families with RET -negative fMTC in 21 affected individuals through linkage analysis, exome/genome sequencing, and high-density array comparative genomic hybridization. We identified a novel heterozygous 40kb intragenic SLC30A9 deletion which segregated with the disease in all affected individuals. The mutant transcript escaped nonsense-mediated decay and resulted in the production of N-terminally truncated proteins via translation reinitiation from in-frame AUG codons located downstream of the deletion. These proteins showed increased stability and their expression in an MTC cell line increased cell proliferation and clonogenic capacity, supporting an oncogenic role. These findings expand the genetic background of fMTC beyond RET mutations and implicate translation reinitiation in the etiology of cancer susceptibility syndromes secondary to structural genomic variants.
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.
Lenalidomide, a maintenance treatment in multiple myeloma first-line therapy, increases the risk of secondary malignancies, including B-cell precursor acute lymphoblastic leukemia (B‑ALL). We present a comprehensive molecular characterization of 57 patients with lenalidomide-associated B-ALL (LenB-ALL), revealing three mutational subgroups: (1) TP53mt (30%), (2) IDH2mt (p.R140Q) (23%) and (3) other, including NRAS/KRASmt. Remarkably, IDH2 R140Q mutations were highly enriched in LenB-ALL compared to primary B-ALL (p<0.001). Furthermore, IKZF1 intragenic deletions - often subclonal and likely RAG-mediated - were observed in 54% (7/13) of IDH2mt LenB-ALL cases. IDH2 mutations were not restricted to the leukemic clone: they persisted during MRD-negative remission and were identified in lymphoid as well as myeloid cell populations using fluorescence-activated cell sorting and single-cell RNA sequencing. This indicates a preleukemic origin of the IDH2 mutation within the context of clonal hematopoiesis. Transcriptomic and DNA methylation analyses revealed a distinct gene expression profile and a DNA hypermethylation phenotype in IDH2mt LenB-ALL, including IDH2mt-specific as well as lenalidomide-associated features. We propose that lenalidomide promotes expansion of IDH2-mutated clonal hematopoiesis and, via IKAROS downregulation, induces a maturation arrest at the B-cell precursor stage. Subsequent genetic or epigenetic alterations render leukemogenesis independent of ongoing lenalidomide exposure. Altogether, these data define IDH2mt B-ALL as a distinct molecular subtype that is markedly overrepresented after lenalidomide treatment and highlight clonal hematopoiesis as a key contributing factor in the development of LenB-ALL.
Alanine-scanning mutagenesis library of MreB reveals distinct roles for regulating cell shape and viability.
The bacterial actin-homolog MreB is a crucial component of the Rod-system (elongasome) that maintains rod shape in many bacteria. It is localized beneath the cytoplasmic membrane, where it organizes the elongasome complex. Depletion or deletion of mreB results in loss of rod shape and cell death; however, the mechanism of how MreB operates is not known. Past studies have reported that mutations in mreB cause varying degrees of cell shape and size alterations based on the type and position of the substitution. To better understand the role of MreB in rod shape formation we have taken the first truly systematic approach by replacing the native copy of mreB with an alanine-scanning mutagenesis library. Surprisingly, we observed stably growing spherical mutants that have lost MreB's function(s) for shape regulation without losing viability. Hence, MreB has vital functions related to growth in addition to shape maintenance that can be separated. In support of this, rod shape suppressor analysis of these spherical mutants only revealed reversions or intragenic mreB mutations, suggesting that MreB is indispensable for rod shape. Additionally, our results imply the elongasome is no longer active in these strains, suggesting a novel way for rod shaped bacteria to synthesize cell wall.
Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling.
Neurofibromatosis type 1 results from mutations in the NF1 gene and its encoded neurofibromin protein. This condition produces multiple symptoms, including tumors, behavioral alterations, and metabolic changes. Molecularly, neurofibromin mutations affect Ras activity, influencing multiple downstream signaling pathways, including MAPK (Raf/MEK/ERK) and PI3K/Akt/mTOR signaling. This pleiotropy raises the question of which pathways could be targeted to treat the disease symptoms, and whether different phenotypes driven by neurofibromin mutations exhibit similar or diverging dependence on the signaling pathways downstream of Ras. To test this, we examined metabolic and behavioral alterations in the genetically tractable Drosophila neurofibromatosis type 1 model. In vivo genetic analysis revealed that behavioral effects of neurofibromin were mediated by MEK signaling, with no necessity for Akt. In contrast, metabolic effects of neurofibromin were mediated by coordinated actions MEK/ERK and Akt/mTOR/S6K/4E-BP signaling. At the systemic level, loss of neurofibromin dysregulated metabolism via molecular effects in interneurons and muscle. These changes were accompanied by altered muscle mitochondria morphology, with no concomitant changes in neuronal ultrastructure or neuronal mitochondria. Overall, this suggests that neurofibromin mutations affect multiple signaling cascades downstream of Ras, which differentially affect metabolic and behavioral neurofibromatosis type 1 phenotypes.
Neurofibromin 1 (NF1) Splicing Mutation c.61-2A>G: From Aberrant mRNA Processing to Therapeutic Implications In Silico.
The neurofibromin 1 (NF1) splice-site mutation c.61-2A>G (rs1131691100) is a rare, pathogenic, autosomal dominant variant that disrupts NF1 tumor-suppressor function, causing neurofibromatosis type 1 (NF1). Its pathogenic mechanism is poorly understood, and the potential for personalized therapeutic genome editing remains unknown due to the absence of a standard framework for investigating splicing disorders. Here, we performed a comprehensive multi-omics analysis of a de novo c.61-2A>G case from South Korea, integrating short- and long-read whole genome sequencing, whole transcriptome sequencing, and methylation profiling. We confirm that c.61-2A>G abolishes the canonical splice acceptor site, activating a cryptic splice acceptor 16 nucleotides downstream in exon 2. This splicing shift generates a 16-nucleotide deletion, causing a frameshift and premature stop codon that truncates the protein's N-terminal region. Long-read sequencing further reveals that the mutation creates a novel CpG dinucleotide, which is methylated in the majority of reads. Finally, we assessed therapeutic correction strategies, revealing that CRISPR-Cas9 prime editing is the only viable approach for in vivo correction. This study provides the first comprehensive multi-omics characterization of the NF1 c.61-2A>G mutation and establishes a minimal framework for precision therapeutic development in silico in monogenic splicing disorders.
Publicações recentes
Case Report: Somatic NF2 mutation in a vestibular schwannoma arising in a patient with neurofibromatosis type 1.
Excessive intraoperative hemorrhage during orthognathic surgery in a patient with neurofibromatosis type 1: a case report and literature review.
Precision restoration of complex cervical instability and decompression for neurofibromatosis type I: a case report using patient-specific 3D-printed templates.
Isolated Anterior Mesenteric Neurofibroma: A Rare Manifestation of Neurofibromatosis Type 1.
Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling.
📚 EuropePMCmostrando 197
Familial medullary thyroid carcinoma secondary to an SLC30A9 intragenic deletion and translation reinitiation.
medRxiv : the preprint server for health sciencesCase Report: Somatic NF2 mutation in a vestibular schwannoma arising in a patient with neurofibromatosis type 1.
Frontiers in oncologyIDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.
BloodAlanine-scanning mutagenesis library of MreB reveals distinct roles for regulating cell shape and viability.
PLoS geneticsExcessive intraoperative hemorrhage during orthognathic surgery in a patient with neurofibromatosis type 1: a case report and literature review.
Oral and maxillofacial surgeryPrecision restoration of complex cervical instability and decompression for neurofibromatosis type I: a case report using patient-specific 3D-printed templates.
Frontiers in surgeryIsolated Anterior Mesenteric Neurofibroma: A Rare Manifestation of Neurofibromatosis Type 1.
CureusMetabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling.
PLoS geneticsOssification of Mandibular Central Giant Cell Granuloma (CGCG) in Neurofibromatosis Type 1 Patients.
Cancer diagnosis & prognosisDuodenal ampullary neuroendocrine tumor, high risk gastrointestinal stromal tumor, and gastric leiomyoma in a patient with neurofibromatosis type 1: a rare case report and literature review.
Frontiers in oncologyUnusual Presentation of Plexiform Neurofibroma Embedded with Large Comedones: A Case Report.
Case reports in dermatologyBilateral juvenile-onset cataracts associated with GCNT2 variants.
Ophthalmic geneticsHigh-Yield DNA-Based Neurofibromatosis Type 1 Diagnostics Reveal Population-Specific Mutation Landscape in 1917 Koreans.
The Journal of molecular diagnostics : JMDCase report of breastfeeding after maternal iodine contrast: neonatal hypothyroidism revealing an underlying congenital disorder.
International breastfeeding journalNeurofibromin 1 (NF1) Splicing Mutation c.61-2A>G: From Aberrant mRNA Processing to Therapeutic Implications In Silico.
International journal of molecular sciencesAlphaGenome-enabled analysis of non-coding regulatory variants underlying RHD expression with wet-lab validation.
bioRxiv : the preprint server for biologyLaryngeal neurofibroma: case report and review of the literature.
Frontiers in oncologyA Large Deletion With a Large Impact: Homozygous 5,600 bp Deletion of the GALNT3 Gene Causing Hyperphosphatemic Tumoral Calcinosis.
Kidney medicineDiagnostic yield of genome sequencing in children with progressive movement disorders.
Brain : a journal of neurologyAltered Neuronal Architecture in Induced Pluripotent Stem Cells-Derived Neurons from Patients with Schizophrenia Harboring CNTNAP2 Deletion.
Stem cells and developmentMutations and structural variants arising during double-strand break repair.
Proceedings of the National Academy of Sciences of the United States of AmericaInternal carotid artery sympathetic plexus neurofibroma - A case report.
Surgical neurology international[Clinical characteristics and genetic analysis of 22 Chinese pedigrees affected with Neurofibromatosis type I].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsCaffeine May Delay the Radiation-Induced Nucleoshuttling of the ATM Kinase and Reduce the Recognition of the DNA Double-Strand Breaks in Human Cells.
BiomoleculesMetachronous Pheochromocytoma and Cholangiocarcinoma in a patient with Neurofibromatosis type 1: a case report.
Oxford medical case reportsInhibition of Cxcr4 chemokine receptor signaling improves habituation learning in a zebrafish model of neurofibromatosis.
Disease models & mechanismsNovel mega-deletion in BFSP1 causing autosomal recessive juvenile cataract in a Pakistani consanguineous family.
Molecular biology reportsPharmacokinetic recall study of Estonian Biobank participants with novel genetic variants in CYP2C19 and CYP2D6.
NPJ genomic medicineAsthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model.
NPJ systems biology and applicationsUnraveling cardiac anomalies in pediatric neurofibromatosis type 1: insights and implications.
European journal of pediatricsNeurofibromatosis Type 1 in Ecuador: genotype-phenotype correlations from a case series.
MedwaveNF1 with Multiple Cardiac Structural Abnormalities Leading to Cerebral Infarction.
Diagnostics (Basel, Switzerland)Bilateral frontal periventricular nodular heterotopia: a distinctive cortical malformation.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology SocietyRUNX1-FPDMM in families with mild thrombocytopenia and platelet function anomalies: a case series.
Frontiers in medicineConcurrent Juvenile Myelomonocytic Leukemia and Gliomas in Patients With Neurofibromatosis Type 1.
Pediatric blood & cancerGenetic activation of ERK2 recapitulates core neurodevelopmental features of Rasopathy syndromes in mice.
bioRxiv : the preprint server for biologyFrom mutation to symptoms: a multi-center study on HNF1B-related nephropathy in Chinese children.
BMC nephrologyA RUNX2 GFP reporter is expressed prior to osteochondral differentiation and models Metaphyseal Dysplasia with Maxillary Hypoplasia and Brachydactyly (MDMHB).
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchLEF1 intragenic deletions: is Wnt'er coming for T-ALL?
BloodPhenotypic characterization of neurofibromatosis type 1 in a large Chinese cohort: A cross-sectional study.
JAAD internationalProtein domain-specific genotype-phenotype correlation study of neurofibromatosis type 1.
Scientific reportsPharmacological inhibition of RAS pathway alleviates spine deformity in a mouse model of neurofibromatosis type 1.
Bone researchGenetics and pathophysiology of Duchenne muscular dystrophy.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrieNeurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation.
CancersChallenges and Progress for Treatment of Malignant Peripheral Nerve Sheath Tumors in the Context of Recent Successes for Sarcoma Therapy.
CancersThe Complete Plastome of 'Mejhoul' Date Palm: Genomic Markers and Varietal Identification.
International journal of molecular sciencesGenetic characterization of a Chinese cohort of suspected pediatric NF1 patients: a large-scale study using optimized whole-exome sequencing.
Journal of human geneticsFurther evidence for a wide phenotypic and mutational spectrum of Cohen syndrome: case report and literature review.
Journal of applied geneticsExploring Optic Glioma and Type 1 Neurofibromatosis: A Literature Review of Case Reports.
Neuro-ophthalmology (Aeolus Press)Coexistence of ulcerative colitis and neurofibromatosis type 1: a case report and literature review.
Frontiers in medicineBibliometric Analysis of Global Research on Cafe-Au-Lait Macules from 2000 to 2025: Development, Collaboration Patterns, and Emerging Trends.
Clinical, cosmetic and investigational dermatologyIntragenic loss-of-function variants in transcription factors MAZ, FOXP1 and SIN3B in colobomatous microphthalmia.
Journal of medical geneticsHigh Allelic Heterogeneity in Kazakhstani Patients with Neurofibromatosis Type 1: Results from the First Molecular Study.
GenesInfantile-Onset Ascending Hereditary Spastic Paraplegia due to a Homozygous ALS2 Exons 24-25 Deletion: Expanding the Genotypic Spectrum.
American journal of medical genetics. Part APreimplantation genetic testing for neurofibromatosis type 1: molecular genetic aspects and impact on reproductive counseling.
Human reproduction (Oxford, England)[Identification of two novel NF1 mutations and genotype-phenotype analysis in patients with neurofibromatosis type 1].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]In Vitro Mouse Lymphoma Cell (L5178Y Tk+/- 3.7.2C) Forward Mutation Assay.
Methods in molecular biology (Clifton, N.J.)A novel multion in a Chinese family with neurofibromatosis type 1: A case report.
MedicineAtaluren-Induced Functional Restoration of Neurofibromin in Fibroblasts From Neurofibromatosis Type 1 Patients With Nonsense Mutations.
MedCommA novel germline NF1 splicing variant drives the onset of an anorectal mucosal melanoma in a patient with a stable and durable nivolumab response.
PathologicaMalignant peripheral nerve sheath tumors in schwannomatosis: systematic review and meta-analysis.
Journal of neurosurgeryMalignant peripheral nerve sheath tumors in schwannomatosis: a case series.
Journal of neurosurgeryComparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute Leukemia.
CancersClinical and molecular characterization of 148 pediatric neurofibromatosis type 1 patients: a single-center study identifying 14 novel variants.
European journal of pediatricsPathogenic Neurofibromatosis type 1 gene variants in tumors of non-NF1 patients and role of R1276.
FEBS open bioSubtype distribution, clinical presentation, and molecular spectrum of neurofibromatosis type 1-associated breast cancer.
Breast (Edinburgh, Scotland)Enhanced detection and characterization of germline structural variants in cancer predisposition genes via genome sequencing.
Genetics in medicine openMalignant Phyllodes Tumor of the Breast in a Young Adult With Neurofibromatosis Type 1.
American journal of medical genetics. Part AOccipital Bone Defect With Meningoencephalocele and Plexiform Neurofibroma in Neurofibromatosis-1.
CureusCase Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring NF1 mutation: a case series and literature review.
Frontiers in oncologyA Case Report: Co-Occurrence of TNRC6B Gene Variant and Xq28 Microdeletion Syndrome With Comprehensive Literature Review.
Birth defects researchCutaneous Neufibroma in the Absence of Classical NF1 Features: A Case Report and Literature Review.
Dermatopathology (Basel, Switzerland)Intragenic TTN Deletions in a Single Family with Dilated Cardiomyopathy.
The application of clinical genetics"To have children or not?" Between desire, responsibility, luck, and guilt: reproductive decision-making in individuals with neurofibromatosis type 1.
Orphanet journal of rare diseasesDisruption of SPECC1L translation initiation by intragenic deletion: novel pathogenic mechanism in Teebi-hypertelorism syndrome.
NPJ genomic medicineQuadruple the Considerations: Four Genetic Conditions Unveiled in the Setting of Developmental Delays Including a Complex DMD Rearrangement, Telomere Biology Disorder, and Neurodevelopmental Disorders.
Journal of child neurologyPharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.
Molecular cancer therapeuticsJuvenile xanthogranuloma as a potential early manifestation of neurofibromatosis type 1: A case report.
MedicineCurrent states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1).
Acta neuropathologica communicationsSignificance of incidental copy number variants in the Duchenne muscular dystrophy gene.
Neuromuscular disorders : NMDDefective but tumorigenic: the evolutionary and functional roles of mutated oncoviruses.
FEMS microbiology reviewsAn Autopsy Case of Neurofibromatosis Type 1 Mutation Detected in a Duodenal Lesion of Malignant Melanoma: A Case Report.
CureusTherapeutic Advances in Neurofibromatosis Type 1: A Focus on Selumetinib.
Skin therapy letterA Novel 1259 bp Intragenic Deletion in the GJB2 Gene in a Mexican Family with Congenital Profound Hearing Loss.
Audiology researchProgress in genetic mechanisms and precise treatment of neurocutaneous syndrome-related epilepsy.
Frontiers in neurologyHeterozygous alterations of GTF2I at the Williams-Beuren syndrome's locus cause a neurodevelopmental disorder.
Journal of medical geneticsProspective characterization of germline variants in patients with gliomas and glioneuronal tumors.
Acta neuropathologicaA Rare Case: Composite Paraganglioma-Ganglioneuroma in a Neurofibromatosis 1 Patient and Literature Review.
Neuro endocrinology lettersSelumetinib Treatment in a Neurofibromatosis Type 1 Child With Second Hit Mutation on the NF1 Gene.
International journal of developmental neuroscience : the official journal of the International Society for Developmental NeuroscienceRENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.
Human genomicsMoyamoya Syndrome, Epilepsy and Hydrocephalus in Neurofibromatosis Type 1.
International journal of developmental neuroscience : the official journal of the International Society for Developmental NeuroscienceLEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β-catenin vulnerability in T-ALL.
BloodEpigenetic Mechanisms in Neurofibromatosis Types 1 and 2.
EpigenomesA Loss-of-Function Variant Causing Primary Autosomal Recessive Hypertrophic Osteoarthropathy.
CureusColorectal cancer in a 13-year-old with constitutional mismatch repair deficiency and MUTYH heterozygosity.
JPGN reportsCharacterizing neurofibromin 1-altered breast cancer through genomic, functional, and clinical analyses.
Virchows Archiv : an international journal of pathologyIntegrated Genomic Approach: A Five Exon Intragenic Deletion in UNC80 Combines With a Novel Splice Variant to Cause IHPRF2 Syndrome in an Italian Family.
American journal of medical genetics. Part AZebrafish neurofibromatosis type 1 mutants show disruption of sleep but not of circadian rhythms.
SleepSerum miRNAs as biomarkers in Neurofibromatosis 1: New promising findings.
Journal of the neurological sciencesRefined genotype-phenotype correlations in neurofibromatosis type 1 patients with NF1 point variants.
Journal of medical geneticsMolecular Basis of Fracture Pseudarthrosis Associated with Neurofibromatosis Type 1.
Journal of the Pediatric Orthopaedic Society of North AmericaIncreased Prevalence of Psychiatric Disorders in Children with RASopathies: Comparing NF1, Noonan Syndrome Spectrum Disorder, and the General Population.
GenesLong-read sequencing for NF1 gene analysis: enhancing diagnostic accuracy for Neurofibromatosis type 1.
Human molecular geneticsSpeech and Language Disorders Associated With 7q31 Deletions Implicating FOXP2.
American journal of medical genetics. Part ACase Report: Phenotypic heterogeneity within an NF1 family: assessment of the pathogenicity of a de novo c.6640dupA shift mutation and a splice variant with an epilepsy phenotype.
Frontiers in neuroscienceSpontaneous peripheral artery rupture in patients with neurofibromatosis type 1.
Journal of vascular surgery cases and innovative techniquesCoupling chromosome organization to genome segregation in Archaea.
Nature communicationsA Fatal Case of Infection-Induced Neurofibromatosis Type 1 in an Adult.
Case reports in oncologyPigmented Birthmarks and Spinal Neurofibromas in KRAS Mosaicism-Not to Be Confused With NF1.
Pediatric dermatologyNew models for MPNST: establishment and comprehensive characterization of two tumor cell lines.
Cancer cell internationalFunctional Analysis of Complex Structural and Splice-Altering Variants in the ARSB Gene Towards the Personalized Antisense-Based Therapy for Mucopolysaccharidosis Type VI Patients.
Human mutationβ-Thalassemia Trait Caused by a SUPT5H Defect: First Report of an Intragenic Deletion.
HemoglobinHigh-Throughput Targeted Drug Screening for NF1-associated High-Grade Gliomas with ATRX Deficiency.
bioRxiv : the preprint server for biologyUtility of Genetic Testing of Various Tissues in Localized Mosaic Neurofibromatosis.
Acta dermatovenerologica Croatica : ADCRare variants modulating phenotype in NF1 carriers.
Scientific reportsAn Isoform-Specific RUNX1C-BTG2 Axis Governs AML Quiescence and Chemoresistance.
Blood cancer discoveryMalignant peripheral nerve sheath tumor in early childhood: a case report of a diagnostic challenge.
Frontiers in oncologyUnraveling novel variants in the NF1 gene and investigating potential therapeutic strategies.
Scientific reportsEffective treatment of non-fusion RET intragenic deletion lung adenocarcinoma with pralsetinib: a case report.
Frontiers in medicineA haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.
The Journal of clinical investigationA transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.
Proceedings of the National Academy of Sciences of the United States of America[A clinical case of type 1 neurofibromatosis associated with a rare genotype].
Zhurnal nevrologii i psikhiatrii imeni S.S. KorsakovaPhase Determination and Demonstration of Parental Mosaicism of Intragenic PRKN Deletions Initially Identified by Chromosomal Microarray Analysis.
Genes[Analysis of clinical characteristics and NF1 gene variants in a child with Neurofibroma-Noonan syndrome].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsCoexistence of Congenital Aniridia and Ptosis in a Patient with Neurofibromatosis Type I: A Case Report.
Case reports in ophthalmologyStructural variation in nebulin and its impact on phenotype and inheritance: establishing a dominant distal phenotype caused by large deletions.
European journal of human genetics : EJHGInhibition of Cxcr4 chemokine receptor signaling improves habituation learning and increases cAMP-PKA signaling in a zebrafish model of Neurofibromatosis type 1.
bioRxiv : the preprint server for biologyNeurofibromatosis Type 1: Clinical and Imaging Perspectives From a Pediatric Case.
Case reports in radiologyEllis-Van Creveld Syndrome with Severe Mitral Valve Insufficiency Caused by a Homozygous Intragenic Deletion of the EVC Gene.
Molecular syndromologyRare Copy Number Variants Intersecting Parkinson's-associated Genes in a Cohort of children With Autism Spectrum Disorders.
Neuroscience insightsUnraveling the molecular landscape of congenital pseudoarthrosis of the tibia: insights from a comprehensive analysis of 159 probands.
Orphanet journal of rare diseasesIrritability in children with RASopathies, insights into emotional dysregulation and social impairment.
European child & adolescent psychiatryResolving the Diagnostic Odyssey in Inherited Retinal Dystrophies Through Long-Read Genome Sequencing.
American journal of medical genetics. Part AThe Role of Artificial Intelligence in Identifying NF1 Gene Variants and Improving Diagnosis.
GenesRecent Advancement of Neurofibromatosis Type 1: A Narrative Review.
Acta neurologica TaiwanicaRapid Malignant Transformation of a Biopsy Proven Sporadic Soft Tissue Schwannoma to Spindle Cell MPNST With TP53 Mutation as an Early Event.
International journal of surgical pathologyClinical and epidemiological characterisation of neurofibromatosis type 1: Combined analysis of a reference hospital in Brazil and DataSUS.
Genetics and molecular biologyGenome sequencing reveals CCDC88A variants in malformations of cortical development and immune dysfunction.
Human molecular geneticsIncreased insulin-like growth factor-1 concentrations in paediatric suprasellar low-grade glioma: an international multicentre study.
European journal of endocrinologyNeurofibromatosis Type 1 : A General Review.
Journal of Korean Neurosurgical SocietyUnderstanding speech and language in KIF1A-associated neurological disorder.
European journal of human genetics : EJHG[Genetic analysis of a fetus pedigree affected with Thyroid dyshormonogenesis type 5 combined with familial Neurofibromatosis type 1].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsLoss of function of the zinc finger homeobox 4 gene, ZFHX4, underlies a neurodevelopmental disorder.
American journal of human geneticsRASopathy syndromes: Understanding signaling pathway disorders leading to tumorigenesis.
Journal of the American Association of Nurse PractitionersMaternal uniparental disomy of chromosome 7: how chromosome 7-encoded imprinted genes contribute to the Silver-Russell phenotype.
Clinical epigeneticsDual Diagnosis of Sifrim-Hitz-Weiss Syndrome and Neurofibromatosis Type 1: Expanding the Phenotype of Cardiac Features in Sifrim-Hitz-Weiss Syndrome and Quick Literature Review.
American journal of medical genetics. Part AGlioblastoma in NF1: A Unique Entity-A Literature Review Focusing on Surgical Implication and Our Experience.
Current oncology (Toronto, Ont.)Generation of human induced pluripotent stem cell lines derived from a patient carrying an intragenic deletion in the NFIA gene.
Human cellA phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4.
Neuro-oncologyUnveiling the complexity of neurofibromatosis type 1: Innovations in genetic understanding and clinical management. A narrative review.
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, CzechoslovakiaLifelong Management of Neurofibromatosis 1 Patients.
Journal of Korean Neurosurgical SocietySmall Intestinal Neurofibroma With Atypical 17q11.2 Microdeletions: A Rare Cause of Abdominal Distension.
JGH open : an open access journal of gastroenterology and hepatologyThe dose-, LET-, and gene-dependent patterns of intragenic DNA changes underlying recessive visible mutations at the autosomal gene cinnabar of Drosophila melanogaster.
Mutation research. Genetic toxicology and environmental mutagenesisFrom benign neurofibromas to malignant peripheral nerve sheath tumors (MPNST): a gaming among multiple factors.
Cellular oncology (Dordrecht, Netherlands)A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations.
Nature communicationsAnalysing tumours for genetic diagnosis in mosaic neurofibromatosis type 1.
Journal of medical geneticsEmerging mechanism and therapeutic potential of neurofibromatosis type 1-related nerve system tumor: Advancing insights into tumor development.
Neuro-oncology advancesModerate to Severe Short Stature and Joint Involvement in Individuals With ACAN Deletions.
Clinical endocrinologyThe CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors.
Scientific reportsCognition and behavior in neurofibromatosis type 1: report and perspective from the Cognition and Behavior in NF1 (CABIN) Task Force.
Genes & developmentIntragenic deletions from whole genome sequencing of 1054 suicide deaths.
medRxiv : the preprint server for health sciencesGastric gastrointestinal stromal tumor in a patient with neurofibromatosis type I presenting with anemia: A case report.
World journal of gastrointestinal oncologyBi-allelic MED16 variants cause a MEDopathy with intellectual disability, motor delay, and craniofacial, cardiac, and limb malformations.
American journal of human geneticsExploring the Prevalence of SMN1 Duplication and Deletion in Russia and Its Impact on Carrier Screening.
International journal of molecular sciencesLysine-specific demethylase 1a is obligatory for gene regulation during kidney development.
bioRxiv : the preprint server for biologyNeurofibromatosis Type 1 (NF1)-Related Ocular Signs: New Insights on Their Prevalence, Incidence, and Genotype-Phenotype Correlation in NF1 Children.
American journal of ophthalmologyA rare unifocal gastric gastrointestinal stromal tumor in a young NF1 patient: A case report.
International journal of surgery case reportsA Rare Coexisting Presentation of Autosomal Dominant Polycystic Kidney Disease With Rapid Deterioration of Renal Function and Neurofibromatosis Type 1.
CureusABCC6 gene mutational spectrum and ocular features in Mexican patients with pseudoxanthoma elasticum-related angioid streaks.
Ophthalmic geneticsClinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC.
ESMO openThe nature and pathological impact of the c.1748A > G variant of the neurofibromin 1 gene.
GeneMolecular insights into genodermatoses: Genetic findings from 43 patients.
Archives of dermatological researchCancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1.
Nature geneticsKBG syndrome: report and follow-up on three unrelated patients observed at different ages.
Italian journal of pediatricsDecade-long application of preimplantation genetic testing for DMD/BMD: analysis of five clinical strategies and embryo recombination patterns.
Human geneticsNeurofibromin Deficiency Alters the Patterning and Prioritization of Motor Behaviors in a State-Dependent Manner.
The Journal of neuroscience : the official journal of the Society for NeuroscienceA scarce case: Co-occurrence of neurofibromatosis type 1 and Klinefelter syndrome.
Global medical geneticsHomozygous Intragenic Deletion in WDR62 in Siblings with Primary Microcephaly.
Molecular syndromologyRare Cause 5q SMA: Molecular Genetic and Clinical Analyses of Intragenic Subtle Variants in the SMN Locus.
Clinical geneticsInteractions of N- and C-terminal parts of Ana1 permitting centriole duplication but not elongation.
Open biologyAdeno-associated viral vector targeted evolution for neurofibromatosis gene delivery.
Trends in molecular medicine[Plastic surgical treatment of neurofibromatosis type 1].
Chirurgie (Heidelberg, Germany)Hepatoblastoma in a patient with neurofibromatosis type 1: A case report.
Cancer geneticsIncreased Phenotype Severity Associated with Splice-Site Variants in a Hungarian Pediatric Neurofibromatosis 1 Cohort: A Retrospective Study.
BiomedicinesAllosteric modulation of NF1 GAP: Differential distributions of catalytically competent populations in loss-of-function and gain-of-function mutants.
Protein science : a publication of the Protein SocietyMitochondrial Complex I Deficiency: Unraveling the Relevance of NDUFAF1 in Pediatric Hypertrophic Cardiomyopathy.
American journal of medical genetics. Part ANeurofibromatosis with diffuse intestinal ganglioneuromatosis: a case report.
Translational cancer researchJaffe-Campanacci Syndrome: A Case Report and Review of the Literature.
CureusMultiple small bowel GIST as GI manifestation of neurofibromatosis type I: A case report.
Radiology case reportsLoss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells.
Cancer research communicationsStructural variation in nebulin and its implications on phenotype and inheritance: establishing a dominant distal phenotype caused by large deletions.
medRxiv : the preprint server for health sciencesHydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors.
Proceedings of the National Academy of Sciences of the United States of AmericaClassification of schwannomas and the new naming convention for "neurofibromatosis-2": Genetic updates and international consensus recommendation.
The neuroradiology journalNovel Intragenic and Genomic Variants Highlight the Phenotypic Variability in HCCS-Related Disease.
GenesIrritability in Children with Rasopathies, Insights into Emotional Dysregulation and Social Skills Impairments.
Research squareStandardization of Genomic Nomenclature across a Diverse Ecosystem of Stakeholders: Evolution and Challenges.
Clinical chemistryAtypical free sialic acid storage disorder associated with tissue specific mosaicism of SLC17A5.
Molecular genetics and metabolismAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Neurofibromatose tipo 1 por mutação ou deleção intragênica em NF1.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Neurofibromatose tipo 1 por mutação ou deleção intragênica em NF1
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Familial medullary thyroid carcinoma secondary to an SLC30A9 intragenic deletion and translation reinitiation.
- IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.
- Alanine-scanning mutagenesis library of MreB reveals distinct roles for regulating cell shape and viability.
- Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling.
- Neurofibromin 1 (NF1) Splicing Mutation c.61-2A>G: From Aberrant mRNA Processing to Therapeutic Implications In Silico.
- Case Report: Somatic NF2 mutation in a vestibular schwannoma arising in a patient with neurofibromatosis type 1.
- Excessive intraoperative hemorrhage during orthognathic surgery in a patient with neurofibromatosis type 1: a case report and literature review.
- Precision restoration of complex cervical instability and decompression for neurofibromatosis type I: a case report using patient-specific 3D-printed templates.
- Isolated Anterior Mesenteric Neurofibroma: A Rare Manifestation of Neurofibromatosis Type 1.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:363700(Orphanet)
- MONDO:0018208(MONDO)
- GARD:17570(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q56014112(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
